Biotricity Q1 FY27 net loss widens 42.8% to $959,468; revenue rises 10.4% to $4.28 million - BTCY News | RalliesBiotricity Q1 FY27 net loss widens 42.8% to $959,468; revenue rises 10.4% to $4.28 million
B
BTCY• Quarterly results
- Biotricity posted a GAAP net loss of $959,468 for the quarter ended June 30, 2026, widening from the prior-year quarter.
- Revenue rose 10.4% to $4.28 million, driven by a 23.6% increase in recurring technology fee revenue to $4.2 million.
- Operating income fell 43.9% to $158,068 as selling, general and administrative expense climbed 26.2% to $2.7 million.
- Gross margin improved 2.1 percentage points to 82.6%; technology fees made up 97.4% of revenue.
- Non-GAAP adjusted EBITDA increased to $499,526; GAAP EBITDA eased to $90,409 on higher share-based compensation.
•
